Maitland Labs of Central Florida | Office of Pharmaceutical Quality Operations, Division II | Compounding Pharmacy/Adulterated Drug Products |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Maitland Labs of Central Florida | Office of Pharmaceutical Quality Operations, Division II | Compounding Pharmacy/Adulterated Drug Products |
T.S.V.L. LLC d/b/a Times Square Vape Lab | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | |||
Old Pueblo Vapor LLC | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | |||
Escape Vape Lounge | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | |||
Broken Coil | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | |||
Midwestern Pet Food | Center for Veterinary Medicine | CGMP/Food for Animals/Prepared, Packed or Held Under Insanitary Conditions/Adulterated | |||
Transu Investment Group, LLC | Division of Southwest Imports | Foreign Supplier Verification Program (FSVP) | |||
1st Phorm LLC | Office of Human and Animal Food West Division II | Unapproved New Drugs/Misbranded | |||
Tropicosmeticos SA de CV | Center for Drug Evaluation and Research | Finished Pharmaceuticals/Unapproved New Drug/Misbranded | |||
Productos Bredy USA LLC | Division of Southwest Imports | Foreign Supplier Verification Program (FSVP) |
Department of Justice
Gulfport – A Monroe, Louisiana man pleaded guilty today to engaging in a multi-million dollar conspiracy to pay illegal health care kickbacks and conspiracy to defraud the United States, announced Acting U.S. Attorney Darren J. LaMarca, Acting Special Agent in Charge Paul Brown with the Federal Bureau of Investigation in Mississippi, and Special Agent in Charge Cynthia A. Bruce of the DoD OIG, Defense Criminal Investigative Service (DCIS) Southeast Field Office.
According to court documents, Thomas “Tommy” Wilburn Shoemaker, 57, admitted that he participated in a scheme to defraud TRICARE and other health care benefit programs by acting as a marketer for World Health Industries, Inc. (“WHI”), a pharmacy specializing in the production of compounded medications. Shoemaker acknowledged that he allowed WHI to use his TRICARE insurance to adjust prescription formulas to ensure the highest reimbursement without regard to efficacy, and he recruited doctors to procure prescriptions for high margin compounded medications. Furthermore, as a marketer, Shoemaker admitted to obtaining numerous fraudulent prescriptions using personal information of military acquaintances. Through his company, he received over $300,000 in commissions for the prescriptions that were reimbursed by TRICARE, and in total, he received at least $672,538.19 in proceeds that were derived directly from the fraud scheme.
Shoemaker is scheduled to be sentenced on November 30, 2021, and faces a maximum penalty of 5 years in prison. A federal district judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.
The Federal Bureau of Investigation and the Defense Criminal Investigative Service are investigating the case.
Trial Attorneys Emily Cohen and Alejandra Arias of the DOJ Criminal Division’s Money Laundering and Asset Recovery Section and Assistant U.S. Attorney Kathlyn Van Buskirk of the Southern District of Mississippi are prosecuting the case with assistance from Sara Porter and Dustin Davis from the DOJ Criminal Division’s Fraud Section.